Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Chemomab Therapeutics Ltd. | Chief Financial Officer | American Depositary Shares | 5.21K | $26.2K | $5.03 | Jun 14, 2023 | Direct |
Chemomab Therapeutics Ltd. | Chief Financial Officer | Option to Purchase American Depositary Shares | 35.6K | Nov 11, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CMMB | Chemomab Therapeutics Ltd. | Jun 14, 2023 | 3 | $0 | 4 | Jun 16, 2023 | Chief Financial Officer |
CMMB | Chemomab Therapeutics Ltd. | Jun 1, 2023 | 0 | $0 | 3 | Jun 5, 2023 | Chief Financial Officer |
CMMB | Chemomab Therapeutics Ltd. | May 7, 2021 | 1 | $0 | 4 | May 10, 2021 | Chief Financial Officer |